Product Reports Resources Pricing Login Book a demo

Xtant Medical

Biotech & Life Sciences · Miamisburg, United States · Founded 1998 · IPO 2011

Medical technology company focused on surgical solutions for the treatment of spinal disorders MoreLess

Xtant Medical is a company specializing in the design, development, and commercialization of orthobiologics and spinal fixation systems. The company serves healthcare providers, particularly those involved in complex, deformity, and degenerative spinal procedures. Operating in the medical device market, Xtant Medical's business model revolves around the manufacturing and distribution of medical devices and human tissues for transplant. The company generates revenue by selling these products to hospitals, clinics, and other healthcare facilities. Xtant Medical aims to improve the quality of life for patients by providing safe and effective medical solutions, honoring the gift of donation, and maximizing the utilization of donated tissues. The company is committed to innovation and quality, ensuring that its products meet the needs of its customers and enhance patient outcomes.

Keywords: orthobiologics, spinal fixation, medical devices, tissue transplant, healthcare providers, complex procedures, degenerative conditions, innovation, quality, patient outcomes.

Valuation $64M
Revenue $102M
EBITDA $2.1M
Total funding $50–100M

Talent graph

Xtant Medical's talent

Book a demo to see the people
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Xtant Medical's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 2 investors entered at this stage
Midcap Financial
Companion Spine

Global footprint

Where Xtant Medical has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
8.4K monthly visits
across markets
🇺🇸 United States86.9%
🇮🇳 India4.8%
🇮🇩 Indonesia4.8%
🇮🇹 Italy2.4%
🇩🇪 Germany1.2%
Top 5 markets shown

Patent intelligence

$49M patent portfolio · 91 active families

Estimated portfolio value
$49M
77.7% of market cap · 7.1× smaller than top peer NovoCure ($352M)
91 active patent families
Where Xtant Medical innovates Biomedical engineeringGeneral surgeryIliac screwImplantImplanted device

Where Xtant Medical concentrates vs peers

Each axis is a top-10 topic across Xtant Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Xtant Medical

An AI-synthesized read of the highest-engagement posts about Xtant Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xtant Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.